Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1122L |
IGF-I 30-41 acetate(82177-09-1 free base)
Insulin-like Growth Factor I (30-41) acetate |
Others | Others |
IGF-I 30-41 acetate(82177-09-1 free base) (Insulin-like Growth Factor I (30-41) acetate) 是胰岛素样生长因子 I (IGF-I) 的氨基酸 30 至 41 片段。 | |||
TP1122 |
IGF-I (30-41)
Insulin-like Growth Factor I (30-41),IGF-I 30-41 |
||
IGF-I (30-41) is amino acids 30 to 41 fragment of Insulin-like Growth Factor I (IGF-I). | |||
TP1124 |
IGF-I (24-41)
Insulin-like Growth Factor I (24-41),IGF-I 24-41 |
||
IGF-I (24-41) is a 24-41 amino acid fragment of Insulin-like Growth Factor I (IGF-I). IGF-I is partly responsible for systemic GH activities although it possesses a wide number of own properties (anabolic, antioxidant, anti-inflammatory and cytoprotective | |||
TP1123 |
IGF-I (24-41) TFA (135861-49-3 free base)
Insulin-like Growth Factor I (24-41) (TFA),IGF-I (24-41) TFA |
||
IGF-I is partly responsible for systemic GH activities although it possesses a wide number of own properties (anabolic, antioxidant, anti-inflammatory and cytoprotective actions).IGF-I (24-41) (TFA) is amino acids 24 to 41 fragment of Insulin-like Growth | |||
TP1121 |
IGF-I (30-41) TFA(82177-09-1,FREE)
Insulin-like Growth Factor I (30-41) (TFA) |
||
IGF-I (30-41) (TFA) is amino acids 30 to 41 fragment of Insulin-like Growth Factor I (IGF-I). | |||
T76012 |
IGF-I (30-41) (TFA)
|
||
IGF-I (30-41) (TFA) 是类胰岛素生长因子I 30 至 41 的氨基酸片段。IGF-I 对生长激素的活性有着重要的作用,但是IGF-I 本身也具有一些自身的特性,如合成代谢、抗氧化、抗炎和细胞保护作用。 | |||
T76014 |
IGF-I (24-41) (TFA)
|
||
IGF-I (24-41) TFA(Insulin-like Growth Factor I (24-41) TFA)是类胰岛素生长因子I的一个氨基酸片段,覆盖24至41位点。作为一种70个氨基酸组成的多肽激素,IGF-I TFA对神经元和神经胶质细胞具有营养作用,而且在调节全身生长激素(GH)活性中扮演关键角色。它还具备合成代谢、抗氧化、抗炎及细胞保护功能,对躯体生长及行为发育调节作用显著。 | |||
T11593 |
I-OMe-Tyrphostin AG 538
I-OMe-AG 538 |
IGF-1R; PI3K | PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors |
I-OMe-Tyrphostin AG 538是一种特异性 IGF-1R 抑制剂和 PI5P4Kα的 ATP 竞争性抑制剂(IC50:1 µM)。I-OMe-Tyrphostin AG 538可抑制 IGF-1R 介导的信号传导,并对营养缺乏的 PANC1细胞具有优先细胞毒性。 | |||
T2085 |
PQ401
IGF-1R Inhibitor II |
Apoptosis; IGF-1R | Apoptosis; Tyrosine Kinase/Adaptors |
PQ401 (IGF-1R Inhibitor II) 是一种IGF-IR 抑制剂。在 MCF-7 细胞中,它抑制 IGF-I 刺激的 IGF-IR 自磷酸化,可有效抑制 IGF-I 刺激的 MCF-7 细胞生长。它诱导 caspase 介导的细胞凋亡,有用于乳腺癌和其他对 IGF-I 敏感的癌症的研究潜力。 | |||
T2160 |
Suramin Sodium Salt
苏拉明钠,BAY-205,Suramin hexasodium salt,苏拉明钠盐,NF-060 |
Apoptosis; Phosphatase; SARS-CoV; Sirtuin; Reverse Transcriptase; Topoisomerase; Parasite | Apoptosis; Chromatin/Epigenetic; DNA Damage/DNA Repair; Metabolism; Microbiology/Virology |
Suramin Sodium Salt (BAY-205) 是可逆的竞争性蛋白酪氨酸磷酸酶抑制剂。它抑制 IP5K,是抗寄生虫,抗肿瘤和抗血管生成剂。它是sirtuins 的有效抑制剂,也是 SARS-CoV-2 RNA 依赖性 RNA 聚合酶抑制剂。 | |||
TP2207 |
Pasireotide Acetate
|
Somatostatin | GPCR/G Protein |
Pasireotide acetate 是长效的环己肽生长激素抑制素类似物,具有抗分泌、抗增殖和促凋亡活性。它可抑制 GH、IGF-I 和 ACTH 的分泌,可用于研究肢端肥大症和库欣病。它还可以提高生长抑素受体的激动剂活性,对sst1、2、3、4、5的pKi 分别为 8.2、9.0、9.1、小于7.0 和 9.9。 | |||
T70568 |
H-1356
|
||
H-1356 is an insulin-like growth factor 1(IGF-I) analog that inhibits autophosphorylation of IGF-I receptor. | |||
T61506 | NBI-31772 hydrate | ||
NBI-31772 hydrate is a powerful inhibitor of the interaction between insulin-like growth factor (IGF) and IGF-binding proteins (IGFBPs). It acts as a nonpeptide ligand, effectively releasing bioactive IGF-I from the IGF-I/IGFBP-3 complex (Ki values for all six human subtypes range from 1-24 nM). This compound demonstrates significant anxiolytic and antidepressant-like effects [1] [2] [3]. | |||
T20534 |
Lanreotide
BIM 23014,Somatulin,Lanreotide Autogel,Somatuline,Ipstyl |
||
Lanreotide, a somatostatin analogue, suppresses GH/IGF-I hypersecretion in acromegaly patients. It also used to manage neuroendocrine tumours. | |||
T73702 |
Mecasermin
|
||
Mecasermin(Human IGF-I; FK 780),一种重组人胰岛素样生长因子I(IGF-I),主要用于研究因生长激素(GH)受体缺陷或GH抑制抗体导致的GH不敏感性而引起的生长障碍。 | |||
T69682 |
AEW541 HCl
|
||
AEW541, also known as NVP-AEW541, is a novel, potent IGF-IR kinase inhibitor. NVP-AEW541 is capable of distinguishing between the IGF-IR (IC50 = 0.086 microM) and the closely related InsR (IC50 = 2.3 microM) in cells. NVP- AEW541 abrogates IGF-I-mediated survival and colony formation in soft agar at concentrations that are consistent with inhibition of IGF-IR autophosphorylation. Note: AEW541 has a Cis-configuration on the cyclobutane ring. Its CAS# is 475489-16-8. Many vendors and Sc-finder sc... | |||
T69221 |
BMS-554417
|
||
BMS-554417 is a novel inhibitor of IGF-IR, which inhibits IGF-IR and insulin receptor kinase activity and proliferation in vitro, and reduces tumor xenograft size in vivo. In a series of carcinoma cell lines, the IC50 for proliferation ranged from 120 nmol/L (Colo205) to >8.5 micromol/L (OV202). BMS-554417 treatment inhibited IGF-IR and insulin receptor signaling through extracellular signal-related kinase as well as the phosphoinositide 3-kinase/Akt pathway, as evidenced by decreased Akt phosph... |